galenica ag-reg
(GALN:SIX Swiss Exchange)
As of 11:58 AM 05/23/13 All times are local (Market data is delayed by at least 15 minutes).
Financial Statements for galenica ag-reg (GALN)
Although debt as a percent of total capital decreased at Galenica Ltd. over the last fiscal year to 41.30%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 55.51 days worth of sales outstanding. Last, Galenica Ltd. is among the least efficient in its industry at managing inventories, with 57.01 days of its Cost of Goods Sold tied up in Inventories.
View Balance Sheet In U.S. Dollar| Currency in Millions of Swiss Francs | As of: | Dec 31 2009 Restated CHF | Dec 31 2010 Restated CHF | Dec 31 2011 CHF | Dec 31 2012 CHF | 4 Year Trend |
| Assets |  | |||||
| Cash and Equivalents | 66.5 | 291.9 | 338.7 | 347.9 | | |
| Short-Term Investments | 7.8 | 7.6 | 6.6 | 7.2 | | |
| Trading Asset Securities | -- | -- | -- | 0.9 | | |
| TOTAL CASH AND SHORT TERM INVESTMENTS | 74.3 | 299.4 | 345.3 | 356.0 | | |
| Accounts Receivable | 505.7 | 489.6 | 501.9 | 497.4 | | |
| Other Receivables | 43.9 | 38.6 | 49.9 | 47.0 | | |
| Inventory | 328.3 | 312.2 | 333.6 | 340.7 | | |
| Prepaid Expenses | 29.5 | 31.9 | 31.4 | 88.9 | | |
| Other Current Assets | 5.8 | -- | -- | 0.8 | | |
| TOTAL CURRENT ASSETS | 987.4 | 1,171.8 | 1,262.2 | 1,330.9 | | |
| NET PROPERTY PLANT AND EQUIPMENT | 450.7 | 448.9 | 447.5 | 438.4 | | |
| Long-Term Investments | 48.3 | 49.5 | 63.3 | 56.6 | | |
| Goodwill | 1,049.9 | 1,028.1 | 1,038.9 | 1,051.6 | | |
| Other Intangibles | 268.1 | 220.1 | 213.4 | 200.0 | | |
| Other Long-Term Assets | 63.9 | 67.6 | 69.0 | 49.6 | | |
| TOTAL ASSETS | 2,895.3 | 3,009.4 | 3,114.2 | 3,146.7 | | |
| ||||||
| LIABILITIES & EQUITY | | |||||
| Accounts Payable | 392.7 | 374.7 | 399.1 | 337.7 | | |
| Accrued Expenses | 140.1 | 130.4 | 131.5 | 165.7 | | |
| Short-Term Borrowings | 165.8 | 32.5 | 46.6 | 126.9 | | |
| Current Portion of Long-Term Debt/Capital Lease | 147.3 | 7.0 | 121.0 | 156.1 | | |
| Other Current Liabilities | 98.3 | 103.3 | 96.7 | 93.3 | | |
| TOTAL CURRENT LIABILITIES | 985.1 | 682.4 | 828.3 | 919.7 | | |
| Long-Term Debt | 1,041.0 | 1,256.3 | 937.0 | 685.1 | | |
| Capital Leases | 1.9 | 1.5 | 1.5 | 1.4 | | |
| Minority Interest | 11.2 | 13.3 | 45.7 | 32.3 | | |
| Other Liabilities, Total | 113.0 | 136.8 | 144.8 | 162.7 | | |
| TOTAL LIABILITIES | 2,141.0 | 2,077.0 | 1,911.6 | 1,768.8 | | |
| Common Stock | 0.7 | 0.7 | 0.7 | 0.7 | | |
| Retained Earnings | 818.8 | 1,038.1 | 1,300.8 | 1,458.5 | | |
| Treasury Stock | -4.5 | -10.2 | -39.3 | -10.8 | | |
| Comprehensive Income and Other | -71.8 | -109.5 | -105.2 | -102.7 | | |
| TOTAL COMMON EQUITY | 743.1 | 919.1 | 1,156.9 | 1,345.6 | | |
| TOTAL EQUITY | 754.3 | 932.4 | 1,202.6 | 1,377.9 | | |
| TOTAL LIABILITIES AND EQUITY | 2,895.3 | 3,009.4 | 3,114.2 | 3,146.7 | | |
| Recently Viewed | |||
| GALN:SW | SFr.625.00 CHF | -6.50 |  |
| Company | Last | Change |
| Cardinal Health Inc | $47.17 USD | -0.42 |
| Celesio AG | €15.98 EUR | -0.62 |
| McKesson Corp | $117.28 USD | -0.27 |
| United Drug PLC | 325.00 GBp | -3.50 |
| Walgreen Co | $50.40 USD | +0.26 |
| View Industry Companies | ||
Industry Analysis
GALN
Industry Average
| Valuation | GALN | Industry Range |
| Price/Earnings | 15.3x |
|
| Price/Sales | 1.1x |
|
| Price/Book | 2.9x |
|
| Price/Cash Flow | 11.8x |
|
| TEV/Sales | 0.7x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
